The 17th International Prostate Forum Program
Saturday, October 13, 2018
GRAND NIKKO TOKYO DAIBA, B1F Room 5 “CHÂTELET”
9:20-9:40
- Opening Remarks and 17th IPF Introduction
- Satoru Takahashi（Nihon University School of Medicine）
John W. Davis（The University of Texas, M.D. Anderson Cancer Center） - Welcome greetings :
-
JUA President Masato Fujisawa
（Kobe University Graduate School of Medicine）IPF Founder Hiroki Watanabe
（Director, Watanabe Memorial Choumei Research Laboratory/Honorary Professor,Kyoto Prefectural University and Meiji University of Integrative Medicine）
9:40-11:00 Session 1: New Diagnostic Methodologies
Moderators:
John W. Davis（The University of Texas, M.D. Anderson Cancer Center）
Mototsugu Oya（Keio University）
- Update on PSA Screening and How to Manage Prior Negative Biopsy
- Badar Mian（Albany Medical Center）
- Role of 3D-Image Based Navigation to Support Lesion-Targeted Prostate Biopsy and Focal Therapy
- Osamu Ukimura（Kyoto Prefectural University of Medicine）
- Genome Testing for Prostate Cancer/ Update Biopsy Results?
- John W. Davis（The University of Texas, M.D. Anderson Cancer Center）
- PET Imaging For Recurrent Prostate Cancer
- Brian F. Chapin（The University of Texas, M.D. Anderson Cancer Center）
11:00-12:20 Session 2: Localized PCA
Moderators:
Derya Balbay（Koc University, School of Medicine）
Shigeo Horie（Juntendo University School of Medicine）
- Active Surveillance
- John W. Davis（The University of Texas, M.D. Anderson Cancer Center）
- Update on Focal Therapy
- Shigeo Horie（Juntendo University School of Medicine）
- Oncologic and Functional Outcomes of RP in High or Very High Risk PCa
- Derya Tilki（University Hospital Hamburg-Eppendorf）
- Management of Localised Prostate Cancer in the Elderly
- A. Erdem Canda（Koc University, School of Medicine）
12:30-13:30 Working Luch
Lecture presented by foreign guest with industry support
13:40-15:00 Session 3: Reccurence and Oligometastatic PCA
Moderators:
Koji Okihara（Kyoto Prefectural University of Medicine）
Derya Tilki（Univershity Hospital Hamburg－Eppendorf）
- Adjuvant vs. Salvage Radiotherapy
- Badar Mian（Albany Medical Center）
- Novel Salvage Permanent Brachytherapy（SPB）Method Based on MRI-TRUS Fusion Biopsy Outcomes.
- Koji Okihara（Kyoto Prefectural University of Medicine）
- Local Treatment in the Setting of Metastatic Disease
- Brian F. Chapin（The University of Texas, M.D. Anderson Cancer Center）
- Prostatectomy For the Patient with Metastatic Prostate Cancer
- Chikara Oyama（Graduate School of Medicine, Hirosaki University）
15:00-16:20 Session 4: High Risk PCA and CRPC Update
Moderators:
Hiroyoshi Suzuki（Sakura Medical Center Toho University）
A. Erdem Canda（Koc University, School of Medicine）
- Lymphadenectomy in Prostate Cancer
- Derya Tilki（University Hospital Hamburg-Eppendorf）
- Crosstalk of AR with Transcriptional Collaborators:Potential Therapeutic Targets
- Daisuke Obinata（Nihon University School of Medicine）
- Treatment Strategies for Metastatic Castration Sensitive Prostate Cancer（mCSPC）
- Hiroyoshi Suzuki（Toho University Sakura Medical Center）
- Layering Novel Systemic Therapy Agents in M0 and M1 CRPC
- Brian F. Chapin（The University of Texas, M.D. Anderson Cancer Center）
16:20-17:00 Case Discussion
Moderators:
Osamu Ukimura（Kyoto Prefectural University of Medicine）
Badar Mian（Albany Medical Center）
Panelists:
Sinichi Sakamoto（Chiba University Graduate School of medicine）
Kohei Hashimoto（Sapporo Medical University of Medicine）
Kazutaka Saito（Tokyo Medical University and Dental University）
17:00-17:10 Closing Remarks
Satoru Takahashi（Nihon University School of Medicine）
John W. Davis（The University of Texas, M.D. Anderson Cancer Center）
